| Year |
Citation |
Score |
| 2014 |
Yoo WC, Rajabbeigi N, Mallon EE, Tsapatsis M, Snyder MA. Elucidating structure-properties relations for the design of highly selective carbon-based HMF sorbents Microporous and Mesoporous Materials. 184: 72-82. DOI: 10.1016/J.Micromeso.2013.10.001 |
0.534 |
|
| 2013 |
Mallon EE, Jeon MY, Navarro M, Bhan A, Tsapatsis M. Probing the relationship between silicalite-1 defects and polyol adsorption properties. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 6546-55. PMID 23635346 DOI: 10.1021/La4001494 |
0.615 |
|
| 2013 |
Mallon EE, Jeon MY, Navarro M, Bhan A, Tsapatsis M. Probing the relationship between silicalite-1 defects and polyol adsorption properties Langmuir. 29: 6546-6555. DOI: 10.1021/la4001494 |
0.566 |
|
| 2011 |
Mallon EE, Babineau IJ, Kranz JI, Guefrachi Y, Siepmann JI, Bhan A, Tsapatsis M. Correlations for adsorption of oxygenates onto zeolites from aqueous solutions. The Journal of Physical Chemistry. B. 115: 11431-8. PMID 21916446 DOI: 10.1021/Jp208143T |
0.548 |
|
| 2010 |
Mallon EE, Bhan A, Tsapatsis M. Driving forces for adsorption of polyols onto zeolites from aqueous solutions. The Journal of Physical Chemistry. B. 114: 1939-45. PMID 20070098 DOI: 10.1021/Jp910543R |
0.625 |
|
| 2010 |
Mallon E, Bhan A, Tsapatsis M. Driving forces for adsorption of polyols onto zeolites from aqueous solutions Acs National Meeting Book of Abstracts. DOI: 10.1021/jp910543r |
0.543 |
|
| 2010 |
Mallon EE, Bhan A, Tsapatsis M. Adsorption of polyfunctional molecules onto zeolites for the development of biorefinery separation processes 10aiche - 2010 Aiche Annual Meeting, Conference Proceedings. |
0.569 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Shamis SA, Savioli F, Ammar A, Al-Badran SS, Hatthakarnkul P, Leslie H, Mallon EE, Jamieson NB, McMillan DC, Edwards J. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay. Histology and Histopathology. 18655. PMID 37681672 DOI: 10.14670/HH-18-655 |
0.099 |
|
| 2019 |
Sestak I, Buus R, Cuzick J, Dubsky P, Kronenwett R, Denkert C, Ferree S, Sgroi D, Schnabel C, Baehner FL, Mallon E, Dowsett M. Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. Jama Oncology. 4: 545-553. PMID 29450494 DOI: 10.1001/jamaoncol.2017.5524 |
0.085 |
|
| 2011 |
Smith C, Ondračková M, Spence R, Adams S, Betts DS, Mallon E. Pathogen-mediated selection for MHC variability in wild zebrafish Evolutionary Ecology Research. 13: 589-605. |
0.083 |
|
| 2023 |
Bliss JM, Tovey H, Evans A, Holcombe C, Horgan K, Mallon E, Vidya R, Skene A, Dodson A, Hills M, Detre S, Zabaglo L, Banerji J, Kilburn L, Morden JP, et al. Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015). Breast Cancer Research : Bcr. 25: 39. PMID 37046348 DOI: 10.1186/s13058-023-01626-3 |
0.078 |
|
| 2003 |
Dowsett M, Bartlett J, Ellis IO, Salter J, Hills M, Mallon E, Watters AD, Cooke T, Paish C, Wencyk PM, Pinder SE. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. The Journal of Pathology. 199: 418-23. PMID 12635131 DOI: 10.1002/path.1313 |
0.074 |
|
| 2014 |
Ferrari N, Mohammed ZM, Nixon C, Mason SM, Mallon E, McMillan DC, Morris JS, Cameron ER, Edwards J, Blyth K. Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer. Plos One. 9: e100759. PMID 24967588 DOI: 10.1371/Journal.Pone.0100759 |
0.073 |
|
| 2022 |
Lopez-Knowles E, Detre S, Hills M, Schuster EF, Cheang MCU, Tovey H, Kilburn LS, Bliss JM, Robertson J, Mallon E, Skene A, Evans A, Smith I, Dowsett M. Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study. Breast Cancer Research : Bcr. 24: 61. PMID 36096872 DOI: 10.1186/s13058-022-01556-6 |
0.072 |
|
| 2015 |
McGreer MT, Mallon EE, Vennen LMV, Wiebe PA, Baker JA, Brown GS, Avgar T, Hagens J, Kittle AW, Mosser A, Street GM, Reid DEB, Rodgers AR, Shuter J, Thompson ID, et al. Selection for forage and avoidance of risk by woodland caribou (Rangifer tarandus caribou) at coarse and local scales Ecosphere. 6. DOI: 10.1890/Es15-00174.1 |
0.071 |
|
| 2005 |
Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Curto García JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis Clinical Cancer Research. 11: 7392-7397. PMID 16243812 DOI: 10.1158/1078-0432.CCR-05-0283 |
0.071 |
|
| 2013 |
Ohotski J, Edwards J, Elsberger B, Watson C, Orange C, Mallon E, Pyne S, Pyne NJ. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer International Journal of Cancer. 132: 605-616. PMID 22733311 DOI: 10.1002/ijc.27692 |
0.07 |
|
| 2024 |
Bartlett JMS, Xu K, Wong J, Pond G, Zhang Y, Spears M, Salunga R, Mallon E, Taylor KJ, Hasenburg A, Markopoulos C, Dirix L, van de Velde CJH, Rea D, Schnabel CA, et al. Validation of the prognostic performance of Breast Cancer Index (BCI) in hormone receptor-positive (HR+) postmenopausal breast cancer patients in the TEAM trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38345755 DOI: 10.1158/1078-0432.CCR-23-2436 |
0.07 |
|
| 2003 |
Bartlett J, Mallon E, Cooke T. The clinical evaluation of HER-2 status: which test to use? The Journal of Pathology. 199: 411-7. PMID 12635130 DOI: 10.1002/path.1354 |
0.068 |
|
| 1996 |
Nagy J, Curry GW, Hillan KJ, McKay IC, Mallon E, Purushotham AD, George WD. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surgical Oncology. 5: 15-21. PMID 8837300 |
0.067 |
|
| 2018 |
Gao Q, López-Knowles E, U Cheang MC, Morden J, Ribas R, Sidhu K, Evans D, Martins V, Dodson A, Skene A, Holcombe C, Mallon E, Evans A, Bliss JM, Robertson J, et al. Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast Cancer. Jnci Cancer Spectrum. 2: pky005. PMID 31360844 DOI: 10.1093/jncics/pky005 |
0.067 |
|
| 2022 |
Xu K, Bayani J, Mallon E, Pond GR, Piper T, Hasenburg A, Markopoulos CJ, Dirix L, Seynaeve CM, van de Velde CJH, Rea DW, Bartlett JMS. Discordance between Immunohistochemistry and ERBB2 mRNA to Determine HER2 Low Status for Breast Cancer. The Journal of Molecular Diagnostics : Jmd. PMID 35526835 DOI: 10.1016/j.jmoldx.2022.04.002 |
0.066 |
|
| 2016 |
Dowsett M, Sestak I, Buus R, Lopez-Knowles E, Mallon E, Howell A, Forbes JF, Buzdar A, Cuzick J. Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2763-70. PMID 26078431 DOI: 10.1158/1078-0432.CCR-14-2842 |
0.066 |
|
| 2016 |
Dowsett M, Sestak I, Buus R, Lopez-Knowles E, Mallon E, Howell A, Forbes JF, Buzdar A, Cuzick J. Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2763-70. PMID 26078431 DOI: 10.1158/1078-0432.CCR-14-2842 |
0.066 |
|
| 2020 |
Smith I, Robertson J, Kilburn L, Wilcox M, Evans A, Holcombe C, Horgan K, Kirwan C, Mallon E, Sibbering M, Skene A, Vidya R, Cheang M, Banerji J, Morden J, et al. Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. The Lancet. Oncology. 21: 1443-1454. PMID 33152284 DOI: 10.1016/S1470-2045(20)30458-7 |
0.065 |
|
| 2023 |
Morrow E, Pennel K, Hatthakarnkul P, Leslie H, Mallon E, Andersen D, Jamieson N, McMillan D, Roseweir A, Edwards J. High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients. Cancer Medicine. PMID 37199043 DOI: 10.1002/cam4.6014 |
0.064 |
|
| 2005 |
Colleoni M, Li S, Gelber RD, Coates AS, Castiglione-Gertsch M, Price KN, Lindtner J, Rudenstam CM, Crivellari D, Collins J, Pagani O, Simoncini E, Thürlimann B, Murray E, Forbes J, ... ... Mallon E, et al. Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: Role of endocrine responsiveness of the tumor Annals of Oncology. 16: 716-725. PMID 15817593 DOI: 10.1093/annonc/mdi163 |
0.063 |
|
| 2016 |
Mohammed ZM, Going JJ, McMillan DC, Orange C, Mallon E, Doughty JC, Edwards J. Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer. Histopathology. 61: 675-84. PMID 22747525 DOI: 10.1111/j.1365-2559.2012.04280.x |
0.063 |
|
| 2000 |
Dowsett M, Cooke T, Ellis I, Gullick WJ, Gusterson B, Mallon E, Walker R. Assessment of HER2 status in breast cancer: why, when and how? European Journal of Cancer (Oxford, England : 1990). 36: 170-6. PMID 10741274 DOI: 10.1016/S0959-8049(99)00264-6 |
0.062 |
|
| 2016 |
Campbell EJ, Tesson M, Doogan F, Mohammed ZM, Mallon E, Edwards J. The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone. British Journal of Cancer. PMID 27657341 DOI: 10.1038/bjc.2016.206 |
0.062 |
|
| 2019 |
Gao Q, López-Knowles E, Cheang MCU, Morden J, Ribas R, Sidhu K, Evans D, Martins V, Dodson A, Skene A, Holcombe C, Mallon E, Evans A, Bliss JM, Robertson J, et al. Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients. Breast Cancer Research : Bcr. 22: 2. PMID 31892336 DOI: 10.1186/s13058-019-1223-z |
0.061 |
|
| 2010 |
Watson C, Long JS, Orange C, Tannahill CL, Mallon E, McGlynn LM, Pyne S, Pyne NJ, Edwards J. High expression of sphingosine 1-phosphate receptors, S1P1and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients American Journal of Pathology. 177: 2205-2215. PMID 20889557 DOI: 10.2353/ajpath.2010.100220 |
0.061 |
|
| 2003 |
Bartlett JMS, Mallon E, Cooke T. Molecular diagnostics for determination of HER2 status in breast cancer Current Diagnostic Pathology. 9: 48-55. DOI: 10.1054/cdip.2002.0155 |
0.061 |
|
| 2015 |
Munzone E, Giobbie-Hurder A, Gusterson BA, Mallon E, Viale G, Thürlimann B, Ejlertsen B, MacGrogan G, Bibeau F, Lelkaitis G, Price KN, Gelber RD, Coates AS, Goldhirsch A, Colleoni M, et al. Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26387144 DOI: 10.1093/annonc/mdv391 |
0.06 |
|
| 2012 |
Mohammed ZMA, Edwards J, Orange C, Mallon E, Doughty JC, Mcmillan DC, Going JJ. Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis Histopathology. 61: 283-292. PMID 22571413 DOI: 10.1111/j.1365-2559.2012.04244.x |
0.06 |
|
| 1997 |
Macmillan RD, Purushotham AD, Mallon E, Love JG, George WD. Tumour bed positivity predicts outcome after breast-conserving surgery British Journal of Surgery. 84: 1559-1562. PMID 9393279 DOI: 10.1002/bjs.1800841119 |
0.059 |
|
| 1996 |
Marren P, Walkden V, Mallon E, Wojnarowska F. Vulval cicatricial pemphigoid may mimic lichen sclerosus British Journal of Dermatology. 134: 522-524. PMID 8731681 |
0.058 |
|
| 2008 |
Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, Holmberg SB, Lindtner J, Snyder R, Thürlimann B, Murray E, Viale G, Castiglione-Gertsch M, Coates AS, Goldhirsch A, et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3006-14. PMID 18458044 DOI: 10.1200/JCO.2007.14.9336 |
0.058 |
|
| 2010 |
Viale G, Giobbie-Hurder A, Gusterson BA, Maiorano E, Mastropasqua MG, Sonzogni A, Mallon E, Colleoni M, Castiglione-Gertsch M, Regan MM, Price KN, Brown RW, Golouh R, Crivellari D, Karlsson P, et al. Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 245-54. PMID 19633051 DOI: 10.1093/annonc/mdp317 |
0.057 |
|
| 2012 |
Ohotski J, Long JS, Orange C, Elsberger B, Mallon E, Doughty J, Pyne S, Pyne NJ, Edwards J. Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer British Journal of Cancer. 106: 1453-1459. PMID 22460268 DOI: 10.1038/bjc.2012.98 |
0.055 |
|
| 1995 |
Macmillan RD, Purushotham AD, Cordiner C, Dobson H, Mallon E, George WD. Predicting local recurrence by correlating pre-operative mammographic findings with pathological risk factors in patients with breast cancer British Journal of Radiology. 68: 445-449. PMID 7788226 |
0.055 |
|
| 2001 |
Davison SC, Allen MH, Mallon E, Barker JNWN. Contrasting patterns of streptococcal superantigen-induced T-cell proliferation in guttate vs. chronic plaque psoriasis British Journal of Dermatology. 145: 245-251. PMID 11531786 DOI: 10.1046/j.1365-2133.2001.04341.x |
0.055 |
|
| 2008 |
Varga Z, Mallon E. Histology and immunophenotype of invasive lobular breast cancer. Daily practice and pitfalls Breast Disease. 30: 15-19. PMID 19850991 DOI: 10.3233/BD-2009-0278 |
0.055 |
|
| 2016 |
Ho W, Stallard S, Doughty J, Mallon E, Romics L. Oncological Outcomes and Complications After Volume Replacement Oncoplastic Breast Conservations-The Glasgow Experience. Breast Cancer : Basic and Clinical Research. 10: 223-228. PMID 28008267 DOI: 10.4137/BCBCR.S41017 |
0.054 |
|
| 2000 |
Mallon E, Osin P, Nasiri N, Blain I, Howard B, Gusterson B. The basic pathology of human breast cancer Journal of Mammary Gland Biology and Neoplasia. 5: 139-163. PMID 11149570 DOI: 10.1023/A:1026439204849 |
0.049 |
|
| 2012 |
Mohammed ZMA, Going JJ, McMillan DC, Orange C, Mallon E, Doughty Julie C. JC, Edwards J. Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer Histopathology. 61: 675-684. DOI: 10.1111/j.1365-2559.2012.04280.x |
0.049 |
|
| 2001 |
Jenkins J, Wilson CR, Smith H, Mallon E, George D. Recurrence and outcome after treatment of ductal carcinoma in-situ of the breast Breast Cancer Research and Treatment. 69: 250. |
0.048 |
|
| 2015 |
Thompson ID, Wiebe PA, Mallon E, Rodger AR, Fryxell JM, Baker JA, Reid D. Factors influencing the seasonal diet selection by woodland caribou (rangifer tarandus tarandus) in boreal forests in ontario Canadian Journal of Zoology. 93: 87-98. DOI: 10.1139/cjz-2014-0140 |
0.047 |
|
| 2013 |
Mohammed ZM, McMillan DC, Edwards J, Mallon E, Doughty JC, Orange C, Going JJ. The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer. Bmc Clinical Pathology. 13: 31. PMID 24274633 DOI: 10.1186/1472-6890-13-31 |
0.047 |
|
| 2012 |
Mohammed ZMA, McMillan DC, Elsberger B, Going JJ, Orange C, Mallon E, Doughty JC, Edwards J. Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer British Journal of Cancer. 106: 383-388. PMID 22251968 DOI: 10.1038/bjc.2011.569 |
0.046 |
|
| 1997 |
Mallon E, Bunce M, Wojnarowska F, Welsh K. HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics Journal of Investigative Dermatology. 109: 183-186. PMID 9242505 |
0.046 |
|
| 2000 |
Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F, Bunker CB. HLA-C and guttate psoriasis. The British Journal of Dermatology. 143: 1177-82. PMID 11122018 DOI: 10.1046/j.1365-2133.2000.03885.x |
0.045 |
|
| 2010 |
Speciner L, Mallon E, Leung S, Laird MW, Esue O. Characterization of a nutrient feed precipitate from an E. coli fermentation process. Biotechnology Progress. 26: 1290-4. PMID 20945485 DOI: 10.1002/btpr.419 |
0.045 |
|
| 2013 |
Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DA, Macmillan RD, Patnick J, Pinder SE. Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. European Journal of Cancer (Oxford, England : 1990). 49: 2294-302. PMID 23523089 DOI: 10.1016/j.ejca.2013.02.031 |
0.044 |
|
| 2013 |
Mohammed ZMA, Orange C, McMillan DC, Mallon E, Doughty JC, Edwards J, Going JJ. Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer Human Pathology. 44: 1688-1695. PMID 23574778 DOI: 10.1016/j.humpath.2012.11.023 |
0.044 |
|
| 2014 |
McGlynn LM, Zino S, MacDonald AI, Curle J, Reilly JE, Mohammed ZM, McMillan DC, Mallon E, Payne AP, Edwards J, Shiels PG. SIRT2: tumour suppressor or tumour promoter in operable breast cancer? European Journal of Cancer (Oxford, England : 1990). 50: 290-301. PMID 24183459 DOI: 10.1016/j.ejca.2013.10.005 |
0.044 |
|
| 2000 |
Mallon E, Hawkins D, Dinneen M, Francis N, Fearfield L, Newson R, Bunker C. Circumcision and genital dermatoses Archives of Dermatology. 136: 350-354. PMID 10724196 |
0.043 |
|
| 1996 |
Nagy J, Curry GW, Hillan KJ, Mallon E, Purushotham AD, George WD. Hepatocyte growth factor/scatter factor, angiogenesis and tumour cell proliferation in primary breast cancer Breast. 5: 105-109. DOI: 10.1016/S0960-9776(96)90131-9 |
0.043 |
|
| 2014 |
Palmieri C, Cleator S, Kilburn LS, Kim SB, Ahn SH, Beresford M, Gong G, Mansi J, Mallon E, Reed S, Mousa K, Fallowfield L, Cheang M, Morden J, Page K, et al. NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer. Breast Cancer Research and Treatment. 148: 581-90. PMID 25395314 DOI: 10.1007/s10549-014-3183-4 |
0.042 |
|
| 2008 |
Ajith Kumar VK, Gold JA, Mallon E, Thomas S, Hodgson SV. Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin. Familial Cancer. 7: 187-9. PMID 17874208 DOI: 10.1007/s10689-007-9161-9 |
0.041 |
|
| 1997 |
Williams F, Mallon E, Middleton D. Development of PCR-SSOP for HLA-A typing of bone marrow registry donors Tissue Antigens. 49: 61-66. PMID 9027968 |
0.04 |
|
| 2001 |
Harrison RF, Jacob S, Spillane H, Mallon E, Hennelly B. A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-β) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles Fertility and Sterility. 75: 23-31. PMID 11163812 DOI: 10.1016/S0015-0282(00)01643-5 |
0.039 |
|
| 2021 |
Bartlett JMS, Bayani J, Kornaga E, Xu K, Pond GR, Piper T, Mallon E, Yao CQ, Boutros PC, Hasenburg A, Dunn JA, Markopoulos C, Dirix L, Seynaeve C, van de Velde CJH, et al. Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study. Npj Breast Cancer. 7: 90. PMID 34238931 DOI: 10.1038/s41523-021-00297-7 |
0.039 |
|
| 2016 |
Mallon EE, Turetsky MR, Thompson ID, Fryxell JM, Wiebe PA. Effects of disturbance on understory succession in upland and lowland boreal forests and implications for woodland caribou (Rangifer tarandus caribou) Forest Ecology and Management. 364: 17-26. DOI: 10.1016/J.Foreco.2015.12.001 |
0.038 |
|
| 2000 |
Cottell E, Harrison RF, McCaffrey M, Walsh T, Mallon E, Barry-Kinsella C. Are seminal fluid microorganisms of significance or merely contaminants? Fertility and Sterility. 74: 465-70. PMID 10973639 DOI: 10.1016/S0015-0282(00)00709-3 |
0.038 |
|
| 1999 |
Brand A, Griffiths DJ, Herve C, Mallon E, Venables PJW. Human retrovirus-5 in rheumatic disease Journal of Autoimmunity. 13: 149-154. PMID 10441180 DOI: 10.1006/jaut.1999.0307 |
0.038 |
|
| 2000 |
Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: Comparing generic and disease-specific measures Journal of the American Academy of Dermatology. 43: 229-233. PMID 10906643 |
0.037 |
|
| 2016 |
Kabir SA, Stallard S, Weiler-Mithoff E, Mansell J, Mallon E, Doughty JC, Romics L. Six-year follow-up of patients treated with oncoplastic reduction mammoplasty: A Cohort Study. International Journal of Surgery (London, England). PMID 26763347 DOI: 10.1016/j.ijsu.2016.01.001 |
0.037 |
|
| 2000 |
Mallon E. Retroviruses and psoriasis Current Opinion in Infectious Diseases. 13: 103-107. |
0.037 |
|
| 1999 |
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. The British Journal of Dermatology. 140: 672-6. PMID 10233319 DOI: 10.1046/j.1365-2133.1999.02768.x |
0.037 |
|
| 1999 |
Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J, Bunker CB. Depletion of cutaneous peptidergic innervation in HIV-associated xerosis Journal of Investigative Dermatology. 112: 284-289. PMID 10084303 DOI: 10.1046/j.1523-1747.1999.00508.x |
0.037 |
|
| 2008 |
Dowsett M, Allred C, Knox J, Quinn E, Salter J, Wale C, Cuzick J, Houghton J, Williams N, Mallon E, Bishop H, Ellis I, Larsimont D, Sasano H, Carder P, et al. Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial Journal of Clinical Oncology. 26: 1059-1065. PMID 18227529 DOI: 10.1200/JCO.2007.12.9437 |
0.036 |
|
| 2003 |
Osborne GEN, Mallon E, Mayou SC. Juvenile sarcoidosis after BCG vaccination Journal of the American Academy of Dermatology. 48: S99-S102. PMID 12734491 DOI: 10.1067/mjd.2003.158 |
0.036 |
|
| 2015 |
Metzger Filho O, Giobbie-Hurder A, Mallon E, Gusterson B, Viale G, Winer EP, Thürlimann B, Gelber RD, Colleoni M, Ejlertsen B, Debled M, Price KN, Regan MM, Coates AS, Goldhirsch A. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2772-9. PMID 26215945 DOI: 10.1200/JCO.2015.60.8133 |
0.035 |
|
| 1997 |
Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. The British Journal of Dermatology. 137: 563-7. PMID 9390332 DOI: 10.1111/j.1365-2133.1997.tb03787.x |
0.034 |
|
| 2000 |
Mallon E, Bunker CB. HIV-associated psoriasis Aids Patient Care and Stds. 14: 239-246. PMID 10833810 DOI: 10.1089/108729100317696 |
0.033 |
|
| 1995 |
Murphy DS, Hoare SF, Going JJ, Mallon EE, George WD, Kaye SB, Brown R, Black DM, Keith WN. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. Journal of the National Cancer Institute. 87: 1694-704. PMID 7473818 |
0.032 |
|
| 2001 |
Setterfield J, Theron J, Vaughan RW, Welsh KI, Mallon E, Wojnarowska F, Challacombe SJ, Black MM. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. The British Journal of Dermatology. 145: 406-14. PMID 11531829 DOI: 10.1046/j.1365-2133.2001.04380.x |
0.032 |
|
| 2011 |
Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, Howell A, Buzdar AU, Forbes JF. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer Journal of Clinical Oncology. 29: 4273-4278. PMID 21990413 DOI: 10.1200/JCO.2010.31.2835 |
0.031 |
|
| 1997 |
Mallon E, Powell S, Mortimer P, Ryan TJ. Evidence for altered cell-mediated immunity in postmastectomy lymphoedema. The British Journal of Dermatology. 137: 928-33. PMID 9470909 |
0.03 |
|
| 1998 |
Reiche L, Wojnarowska F, Mallon E. Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: Further support for its efficacy Clinical and Experimental Dermatology. 23: 254-257. PMID 10233619 DOI: 10.1046/j.1365-2230.1998.00379.x |
0.028 |
|
| 2004 |
Leroux K, Mallon E, Ayliffe WH. Chronic granulomatous disease and peripheral ulcerative keratitis: a rare case of recurrent external ocular disease. Bulletin De La SociéTé Belge D'Ophtalmologie. 47-53. PMID 15510722 |
0.025 |
|
| 1996 |
Drudy L, McCaffrey M, Mallon E, Harrison R. Spermatozoal DNA flow cytometry and recurrent miscarriage. Archives of Andrology. 37: 143-7. PMID 8939291 DOI: 10.3109/01485019608988515 |
0.025 |
|
| 1996 |
Papadavid E, Dover R, Mallon E, Dawber RPR. Marie Unna hypotrichosis: An autosomal dominant hair disorder Journal of the European Academy of Dermatology and Venereology. 7: 279-283. DOI: 10.1016/S0926-9959(96)00067-0 |
0.024 |
|
| 1996 |
Bissett D, Mallon E, Reed NS, George WD, Harnett AN. Cystosarcoma phylloides: Heterogeneity in a rare tumour type Journal of the Royal College of Surgeons of Edinburgh. 41: 244-245. PMID 8772074 |
0.023 |
|
| 2008 |
Varga Z, Mallon E. Infiltrating lobular carcinoma: Four case illustrations Breast Disease. 30: 57-61. PMID 19850997 DOI: 10.3233/BD-2009-0285 |
0.022 |
|
| 1999 |
Griffiths DJ, Cooke SP, Hervé C, Rigby SP, Mallon E, Hajeer A, Lock M, Emery V, Taylor P, Pantelidis P, Bunker CB, Du Bois R, Weiss RA, Venables PJW. Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus Arthritis and Rheumatism. 42: 448-454. PMID 10088767 DOI: 10.1002/1529-0131(199904)42:3<448::Aid-Anr9>3.0.Co;2-8 |
0.021 |
|
| 2011 |
Dowsett M, Salter J, Zabaglo L, Mallon E, Howell A, Buzdar AU, Forbes J, Pineda S, Cuzick J. Predictive algorithms for adjuvant therapy: TransATAC Steroids. 76: 777-780. PMID 21470560 DOI: 10.1016/j.steroids.2011.02.032 |
0.02 |
|
| 1996 |
Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma: Assessment of one and two freeze-thaw cycle schedules Dermatologic Surgery. 22: 854-858. PMID 9246168 |
0.02 |
|
| 1997 |
Mallon E, McKee PH. Extraordinary case report: Cutaneous anthrax American Journal of Dermatopathology. 19: 79-82. PMID 9056659 DOI: 10.1097/00000372-199702000-00014 |
0.019 |
|
| 2015 |
Avgar T, Baker JA, Brown GS, Hagens JS, Kittle AM, Mallon EE, McGreer MT, Mosser A, Newmaster SG, Patterson BR, Reid DE, Rodgers AR, Shuter J, Street GM, Thompson I, et al. Space-use behaviour of woodland caribou based on a cognitive movement model. The Journal of Animal Ecology. 84: 1059-70. PMID 25714592 DOI: 10.1111/1365-2656.12357 |
0.017 |
|
| 1995 |
Mallon E, Wojnarowska F, Hope P, Elder G. Neonatal bullous eruption as a result of transient porphyrinemia in a premature infant with hemolytic disease of the newborn Journal of the American Academy of Dermatology. 33: 333-336. PMID 7615880 DOI: 10.1016/0190-9622(95)91428-5 |
0.013 |
|
| 2015 |
Johnson B, Atia W, Kuznetsov M, Cook C, Goldberg B, Wells B, Larson N, Mc Kenzie E, Melendez C, Mallon E, Woo S, Murdza R, Whitney P, Flanders D. Swept light sources Optical Coherence Tomography: Technology and Applications, Second Edition. 639-658. DOI: 10.1007/978-3-319-06419-2_21 |
0.01 |
|
| 2011 |
Gallanagh S, Walters M, Mallon E, Sonnecki P. Fibroelastoma of the mitral valve as a cause of embolic cerebral infarction. Bmj Case Reports. 2011. PMID 22689548 DOI: 10.1136/bcr.02.2011.3855 |
0.01 |
|
| 2008 |
Mallon E, Varga Z. Relapse of invasive lobular carcinoma Breast Disease. 30: 53-56. PMID 19850996 DOI: 10.3233/BD-2009-0284 |
0.01 |
|
| 2000 |
Ellis IO, Dowsett M, Bartlett J, Walker R, Cooke T, Gullick W, Gusterson B, Mallon E, Lee PB. Recommendations for HER2 testing in the UK. Journal of Clinical Pathology. 53: 890-2. PMID 11265171 DOI: 10.1136/jcp.53.12.890 |
0.01 |
|
| 1999 |
Mallon E, Newson R, Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: A meta-analysis of published serologic studies [2] Journal of Investigative Dermatology. 113: 693-695. PMID 10504461 DOI: 10.1046/j.1523-1747.1999.00724.x |
0.01 |
|
| 1999 |
Mallon E, Osborne G, Dinneen M, Lane RJM, Glaser M, Bunker CB. Dermatomyositis in association with transitional cell carcinoma of the bladder Clinical and Experimental Dermatology. 24: 94-96. PMID 10233662 DOI: 10.1046/j.1365-2230.1999.00415.x |
0.01 |
|
| 1998 |
Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R, Bunker CB. HLA-Cw*0602 and HIV-associated psoriasis. The British Journal of Dermatology. 139: 527-33. PMID 9767306 DOI: 10.1046/j.1365-2133.1998.02495.x |
0.01 |
|
| 1997 |
Mallon E, Ross JS, Hawkins DA, Dinneen M, Francis N, Bunker CB. Biopsy of male genital dermatosis. Genitourinary Medicine. 73: 421. PMID 9534761 |
0.01 |
|
| 1997 |
Mallon E, Ross JS, Hawkins DA, Dinneen M, Francis N, Bunker CB. Biopsy of male genital dermatoses Sexually Transmitted Infections. 73: 421. DOI: 10.1136/sti.73.5.421-a |
0.01 |
|
| 1997 |
Mallon E, Bunker C. Slides in dermatology: 1 Hospital Medicine. 57: 159-161. |
0.01 |
|
| 1997 |
Mallon E, Bunker C. Slides in dermatology: 2 Hospital Medicine. 57: 262-264. |
0.01 |
|
| 1997 |
McCaffrey M, Cottell E, Keane D, Mallon E, Walsh T, McMorrow J, Cafferkey M, O'Kelly E, Harrison R. Bacterial vaginosis and infertility International Journal of Std and Aids. 8: 25. |
0.01 |
|
| Hide low-probability matches. |